1. Role of Galectins in Tumors and in Clinical Immunotherapy
   Feng-Cheng Chou et al, 2018, International Journal of Molecular Sciences CrossRef
2. Galectin-9 in Gastroenterological Cancer
   Asahiro Morishita et al, 2023, International Journal of Molecular Sciences CrossRef
3. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
   Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
4. Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
   Inês Gomes Ferreira et al, 2018, International Journal of Molecular Sciences CrossRef
5. A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
   Yan Lv et al, 2023, Genes & Diseases CrossRef
6. Vascular mimicry: changing the therapeutic paradigms in cancer
   Nazila Fathi Maroufi et al, 2020, Molecular Biology Reports CrossRef
7. IgE Antibodies against Cancer: Efficacy and Safety
   Jitesh Chauhan et al, 2020, Antibodies CrossRef
8. Glycan–Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them
   Stefanie Maria Kremsreiter et al, 2021, International Journal of Molecular Sciences CrossRef
9. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
   Rina Nakajima et al, 2019, Journal of Dermatological Science CrossRef
10. Galectin-9: From cell biology to complex disease dynamics
    Sebastian John et al, 2016, Journal of Biosciences CrossRef
11. The emerging role of galectins in high-fatality cancers
    Cherylane Dubé-Delarosbil et al, 2018, Cellular and Molecular Life Sciences CrossRef
12. The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma
    Zhi‐Jie Xiao et al, 2024, Advanced Science CrossRef
13. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery
    Songyang Wu et al, 2016, Tumor Biology CrossRef
14. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells
    Emiko Akashi et al, 2017, Oncology Reports CrossRef
15. Immunomodulation exerted by galectins: a land of opportunity in rare cancers
    Laura Díaz-Alvarez et al, 2023, Frontiers in Immunology CrossRef
16. The Role of Glycans in Chronic Inflammatory Gastrointestinal and Liver Disorders and Cancer
    Ângela Fernandes et al, 2021, Comprehensive Glycoscience CrossRef
17. Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion
    Pietro Bertino et al, 2019, OncoImmunology CrossRef
18. Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
    Peixin Chen et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
19. Cancer Therapy Due to Apoptosis: Galectin-9
    Koji Fujita et al, 2017, International Journal of Molecular Sciences CrossRef
20. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
    Tomoko Tadokoro et al, 2017, International Journal of Oncology CrossRef
21. AllergoOncology – the impact of allergy in oncology: EAACI position paper
    E. Jensen‐Jarolim et al, 2017, Allergy CrossRef